News
-
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Gedeon Richter Highlights Expanding Biosimilars Portfolio and Scientific Engagement at EULAR 2026
Richter's Biotechnology Business Unit participates in EULAR Congress, highlighting biosimilars. Symposium focuses on disease management. Commitment to advancing patient care and innovation